[173] A 2025 observational study reported a modest increased risk of a serious eye condition in people with diabetes taking glucagon-like peptide-1 (GLP-1) receptor agonists
ACS Chem Neurosci 12:573580 Zordoky BN, Sung MM, Ezekowitz J, Mandal R, Han B, Bjorndahl TC, Bouatra S, Anderson T, Oudit GY, Wishart DS, Dyck JR, Alberta H (2015) Metabolomic fingerprint of heart failure with preserved ejection fraction
Specific injection timing, dose escalation schedules, and individual protocol decisions belong in a clinical conversation with a qualified prescriber
At Ivm Health, were here to support you every step of the way